ILIKA PLC

Declaration of Voting Results & Voting Rights Announcements • Apr 26, 2023

National Storage Mechanism | Additional information

RNS Number : 4005X

Ilika plc

26 April 2023

Ilika plc

("Ilika" or the "Company")

Exercise of Options and Total Voting Rights

Ilika (AIM: IKA), a pioneer in solid-state battery technology announces that on 21 April 2023, following the vesting of options under the Company's EMI share option schemes, 5,750 options with an exercise price of 21p, together with 210,000 options with an exercise price of 18.2p, and a further 375,000 options with an exercise price of 25.5p have been converted into ordinary shares of one penny each in the Company ("Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for 590,750 Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 27 April 2023.

The options represent in aggregate 0.37 per cent of the Company's issued share capital.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 158,474,367 ordinary shares of one penny each and that number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury. 

For more information contact:
Ilika plc		www.ilika.com
Graeme Purdy, Chief Executive		Via Walbrook PR
Liberum Capital Limited (Nomad and Joint Broker)		Tel: 020 3100 2000
Andrew Godber,
William Hall, Nikhil Varghese
Joh. Berenberg, Gossler & Co. KG (Joint Broker)		Tel: 020 3207 8700
Matthew Armitt, Mark Whitmore, Detlir Elezi,
Mara Grasso
Walbrook PR Ltd	Tel: 020 7933 8780 / Ilika@walbrookpr.com
Lianne Applegarth		Mob: 07584 391 303
Nick Rome		Mob: 07748 325 236
Tom Cooper		Mob: 07971 221 972

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCNKPBQKBKDKQB